Vanguard Fiduciary Trust’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Sell
182,402
-11,034
-6% -$47.6K ﹤0.01% 3134
2026
Q1
$716K Buy
+193,436
New +$812K ﹤0.01% 3073

Other funds holding RCEL

Vanguard Fiduciary Trust's RCEL Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Avita Medical (RCEL) stake by 5.7% in Q2 2026, selling an estimated $47.6K and leaving 182,402 shares worth $753K. The position accounts for ﹤0.01% of the portfolio, ranked #3134.

Vanguard Fiduciary Trust first reported a position in RCEL in Q1 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Vanguard Fiduciary Trust held 182,402 shares of Avita Medical worth $753K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 11,034 Avita Medical shares in Q2 2026, an estimated $47.6K.
  • Avita Medical made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3134 holding.
  • Vanguard Fiduciary Trust first reported a position in Avita Medical in Q1 2026 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.